Erika D Cherk, MD
Allergy/Immunology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 3
Offices
3 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Cherk’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A183369 · Current
Licensed to practise in California · since 2022 · expires 2029-01-31 · University of California, San Diego School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$13,939
Pharmacies billed $13,939 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 33) in 2024. Too few prescriptions to compare fairly with other clinicians.
24 generic and fewer than 11 brand-name prescriptions · $13,939 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Fluticasone Propionate | 11 | $216 | $20 |
Money from drug and device companies
$1,675 in 2025
| 2025 | 7 | 12 | None | $1,675 |
| 2024 | 1 | 1 | None | $167 |
| 2023 | 2 | 2 | None | $952 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Jubilant HollisterStier | None | $1,406 | 1 payment
|
| Genzyme | Dupixent | $68 | 3 payments
|
| Novartis Pharmaceuticals | Xolair | $55 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Tezspire | $47 | 2 payments
|
| Genentech USA | Xolair | $39 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $36 | 1 payment
|
See all 12 published payments
| GlaxoSmithKline | Meals · 2025-12-19 | Nucala | $25 |
| Novartis Pharmaceuticals | Meals · 2025-12-18 | Xolair | $21 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-12-17 | Fasenra | $16 |
| Novartis Pharmaceuticals | Meals · 2025-12-12 | Xolair | $33 |
| Genentech USA | Meals · 2025-12-11 | Xolair | $16 |
| Genzyme | Meals · 2025-12-10 | Dupixent | $19 |
| Genzyme | Meals · 2025-11-26 | Dupixent | $21 |
| Genzyme | Meals · 2025-11-26 | Ayvakit | $29 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-21 | Tezspire | $31 |
| Regeneron Healthcare Solutions | Meals · 2025-11-13 | Dupixent | $36 |
| Genentech USA | Meals · 2025-11-05 | Xolair | $23 |
| Jubilant HollisterStier | Education · 2025-05-15 | None | $1,406 |
See earlier years (2024, 2023)
2024: $167
| Grifols USA | Xembify | $167 | 1 payment
|
2023: $952
| Genzyme | None | $800 | 1 payment
|
| Grifols USA | Xembify | $152 | 1 payment
|
Professional record
- NPI
- 1871129882
- Licence
- CA A183369California A183369: Current · expires 2029-01-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207K00000X (207K00000X); Pediatrics (208000000X)
- Mailing address
- 795 El Camino Real, Palo Alto, CA, 94301
- NPI first listed
- 2020-03-21
- NPI last updated
- 2025-12-05
- NPI record certified
- 2025-12-05
This is when the NPI record was last certified, not a medical board exam.